Harry H. Yoon, MD, MHS, discusses tislelizumab and platinum-containing chemotherapy in unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1 at a level of 1 or ...

There are two primary types of esophageal cancer: adenocarcinoma and squamous cell carcinoma. Esophageal cancer is primarily divided into two types: adenocarcinoma and squamous cell carcinoma.

“FDA approval of TEVIMBRA for the first-line treatment of advanced esophageal squamous cell carcinoma marks a significant step forward in tackling the unmet needs in this challenging disease are ...

Active surveillance (AS) following a complete clinical response to neoadjuvant chemoradiotherapy was noninferior to standard ...

Medically reviewed by Marla Anderson, MD Stomach cancer—or gastric cancer—occurs when cells in the lining of the stomach wall ...

The combination of sintilimab and fruquintinib received conditional approval from China’s National Medical Products Administration (NMPA) for the treatment of patients with advanced endometrial cancer ...

CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of a�Type II variation application�to the ...

Comedian Katherine Ryan revealed she has the deadliest form of skin cancer today, after being told by doctors twice that she ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...